Insight

Aug 28, 2025, 16:12

Redefining Precision Medicine Beyond Oncology with AI and Real-World Data – Amgen

Amgen shared a post on X:

”What does precision medicine look like beyond oncology?

Amgen’s Michael Montalto joined the Talking Precision Medicine podcast to talk about how we’re expanding the definition across therapeutic areas with AI and real-world data leading the way.

Catch a preview and listen to the full episode here.”

More posts featuring Amgen.

AI Amgen cancer Michael Montalto OncoDaily Oncology Talking Precision Medicine

10 Leading Experts Join OncoDaily Journal Editorial Team

Top 10 Oncogrants of the Week: Fueling Cancer Research and Innovation

Soon-Shiong’s “Bioshield” Sparks Early Promise in Recurrent GBM, With 2 Near-CRs and 100% Disease Control

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Trial Updates

Aug 28, 2025, 16:14

Paolo Tarantino: Abemaciclib Improves Survival in High-Risk HR Positive HER2 Negative Breast Cancer

Insight

Aug 28, 2025, 16:12

Redefining Precision Medicine Beyond Oncology with AI and Real-World Data - Amgen

Voices

Aug 28, 2025, 16:10

Special Message from JPORP Advisory Board Member Clarissa Schilstra - IPOS

Radiotherapy

Aug 28, 2025, 16:02

Jeff White: Shining a Light on World Radiation Therapy Awareness Day

Insight

Aug 28, 2025, 15:59

Primoz Petric: INTERLACE - Not a New Standard for Cervical Cancer Chemoradiation

Trial Updates

Aug 28, 2025, 15:56

Raul Cordoba: COVID-19 and Bispecific Antibodies in Blood Cancer

Trial Updates

Aug 28, 2025, 15:55

David Heredia: LEOPARD Study Highlights Early NSCLC Recurrence

Trial Updates

Aug 28, 2025, 15:55

ANKTIVA NK Cell Therapy Shows 100 Percent Disease Control in Recurrent Glioblastoma - ImmunityBio

Insight

Aug 28, 2025, 15:54

Bishal Gyawali: Inferior Control Arms in LMIC Oncology Trials in a New BMJ Oncology Editorial

Voices

Aug 28, 2025, 15:53

Talha Badar: TP53-Mutated MPN in British Journal of Haematology

Career Updates

Aug 28, 2025, 15:52

Hassan Abushukair: Celebrating My Term as Co-Chair of the AACR Global Scholars Alumni Committee

Voices

Aug 28, 2025, 15:48

ESO and OECI Invite Clinicians and Researchers to Contribute to the 10th CCI4EU Training Cours